Wasn't it fascinating to read the July 29 news about Michigan-based Perrigo buying Ireland's biotech company Elan for $8.6 billion? The combined entity, to be called New Perrigo, will be incorporated in Ireland. So in one fell swoop, drug maker Perrigo establishes a superb base for further international expansion and, by moving headquarters to Ireland, slashes its tax bill nearly in half.
展开▼